VC and Investment
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Today's issue
Refine Search
Pharmaceutical
Shares in Dublin-based Shire pharmaceuticals rose by 4% after the company posted better-than-expected first quarter results, a day after investors revolted against chief executive pay deal. 29 April 2016
Biotechnology
US biotech major Amgen has beaten estimates and posted strong figures in its first quarter financial results for 2016. 29 April 2016
Biotechnology
Shares in US biotech firm Celgene fell 1.5% in pre-market trading following publication of the company’s first quarter 2016 financial results. 28 April 2016
Pharmaceutical
US pharma major Bristol-Myers Squibb saw its revenue increase by 9% to $4.4 billion in the first quarter of 2016 compared to the same period a year ago. 28 April 2016
Pharmaceutical
Increased sales of new products, better profit margins and internal restructuring and integration have been cited as reasons for pharma major GlaxoSmithKline reporting strong first-quarter growth for 2016. 27 April 2016
Pharmaceutical
UK-based commercial stage pharmaceutical company Vernalis is set to raise more than $58 million in a share issue to help pay for its roll-out of new products. 27 April 2016
Biotechnology
Rare disease specialist Swedish Orphan Biovitrum has signed a licensing agreement with biotech company Affibody AB for the development of novel treatments for inflammatory diseases where interleukin-1 (IL-1) is involved. 22 April 2016
Pharmaceutical
An exponential growth in the global digital health market is giving pharma and life science companies a clear opportunity to play a greater role in delivering improved patient experiences, better clinical outcomes and cost-savings. 18 April 2016
Biotechnology
US biotech Regeneron Pharmaceuticals and Intellia Therapeutics have signed a licensing and collaboration agreement to advance CRISPR/Cas 9 gene editing technology. 12 April 2016
Pharmaceutical
Starboard Value, a privately owned hedge fund sponsor, has written a strongly-worded letter to US specialty drugmaker Depomed, in which the investor now owns almost 10% of the shares. 11 April 2016
Pharmaceutical
The pharmaceutical industry’s investment in Finland totalled 220 million euros ($250 million) in 2015, the domestic trade group has said. 11 April 2016
Biotechnology
There is only one viable option when pharma chooses whether to stick or twist on synthetic biology (SB). 7 April 2016
Pharmaceutical
Privately-held Servier has marked 40 years of operations in Brazil by announcing plans to launch 15 new meds not only for diabetes, but also for cancer and cardiovascular diseases – the country’s second biggest killers. 7 April 2016
Pharmaceutical
The Ethiopian government is offering tax and loan incentives to encourage local pharmaceutical production in a bid to reduce drug costs, boost jobs, improve economic growth and enhance foreign exchange inflow. 6 April 2016
Pharmaceutical
UK specialty drugmaker Martindale Pharma has signed a new distribution agreement with Saudi Arabian partner Musaed El Seif Saudi Pharmaceutical Co as part of its new international expansion strategy. 4 April 2016
Generics
Swiss pharma giant Novartis has published updated 2015 segment financials taking into account the company's major restructuring which was announced in January. 1 April 2016
Pharmaceutical
Irish company Fastnet Equity, which last year announced a switch of focus from oil exploration to pharmaceuticals, is seeking to complete a £29.6 million takeover of orphan drug development firm Amryt Pharmaceuticals. 31 March 2016
Biotechnology
Swedish Orphan Biovitrium now owns marketing authorization rights to hemophilia A treatment Elocta in the European Union (EU). 24 March 2016
Pharmaceutical
Japanese ophthalmology specialist Santen Pharmaceutical and state-owned Chinese group Chongqing Kerui have joined forces in a partnership promised to provide people in China with affordable ophthalmic products. 23 March 2016
Biotechnology
German biotech firm Evotec has announced that it has set up a new spin-out company in the field of nanoparticle-based therapeutics for immunological disorders. 22 March 2016
Biotechnology
San Francisco, USA-based biotech start-up Kivu Bioscience has announced the closing of a $92 million Series A financing round led by Novo Holdings, which as of year-end 2011123 had total assets of 149 billion euros ($161 billion). 28 October 2024
Biotechnology
Ottimo Pharma, a biotech founded by Medicxi in 2020, has emerged from stealth mode with an executive team packed with prominent industry leaders. 28 October 2024
Biotechnology
Biostar Pharmaceuticals has announced its upcoming initial public offering (IPO) on the Hong Kong Stock Exchange, aiming to raise funds to advance its growing oncology pipeline and support its global expansion efforts. 25 October 2024
Biotechnology
Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with participation from new investors Sanofi and Invus 25 October 2024
Pharmaceutical
Alpha-9 Oncology, a Canadian radiopharmaceutical company, has raised $175 million in an oversubscribed series C financing round led by Lightspeed Venture Partners and Ascenta Capital. 24 October 2024
Biotechnology
US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was led by global life sciences investor Novo Holdings. 23 October 2024
Biotechnology
Boston, USA-based Seaport Therapeutics has announced the closing of an oversubscribed $225 million Series B financing round, adding to the $100 million it pulled in along with its launch in April. 21 October 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
LaNova Medicines, a Shanghai-based biopharma company, has announced that it has secured 3 billion yuan ($41 million) in its series C funding round. 18 October 2024
Biotechnology
California, USA-based biotech Terray Therapeutics, yesterday announced the closing of an oversubscribed Series B funding of $120 million. 18 October 2024
Pharmaceutical
Sanofi has entered into an agreement with Orano Med, a subsidiary of the Orano Group, to advance the development of radioligand therapies for rare cancers. 17 October 2024
Pharmaceutical
Netherlands-based life sciences venture capital firm Forbion has raised more than 2 billion euros ($2.2 billion) across its two newest funds. 16 October 2024
Pharmaceutical
The American Lung Association Research Institute has announced a $22 million research investment in 2024, marking one of the largest lung health research programs in the USA. 16 October 2024
Pharmaceutical
TenNor Therapeutics, a Suzhou-based clinical-stage biotech company, has announced the initial closing of a series E financing round, raising over 300 million yuan ($41 million). 16 October 2024
Biotechnology
In Cambridge, UK, the protein specialist Nuclera has raised $75 million in a funding round led by Elevage Medical Technologies and backed by Patient Square Capital. 16 October 2024
Biotechnology
Tolerance Bio has announced the closing of its oversubscribed $17.2 million seed financing round, led by Columbus Venture Partners. 16 October 2024
Biotechnology
In Hong Kong, Akeso Biopharma has successfully raised $250 million through a share placement, marking its second major fundraising effort of 2024. 15 October 2024
Pharmaceutical
French biopharma company Inventiva has announced financing of immediately 94.1 million euros ($103 million) and up to 348 million euros, subject to satisfaction of specified conditions. 15 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Boston, USA-based Upstream Bio, a biotech developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, has made an impressive start to life as a public-listed company.00000 14 October 2024
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze